Sponsors can start by conducting more trials at sites that treat large numbers of women.
If studies continue to run primarily at centers that serve mostly men, then little will change. The only way to have equal confidence in the results for both men and women is to enroll equal numbers of each. Body weight, hormonal variation, and menstruation are understudied variables. The nature, frequency and severity of toxicities seem to be different for women. Women may typically have lower viral loads than men.